Reece et al. engineered the Rv3407 gene into the BCG vaccine and immunized mice with the recombinant BCG vaccine, and found that this modified BCG vaccine stimulated high levels of IFN‐γ production in mice and markedly enhanced protection against TB [37]. The gene discussed is IFNG; the disease is tuberculosis.